Elevai Labs【ELAB】銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.0213

買値

0.0208

売値

0.0214

出来高

199,363,090

0.0197 日の範囲 0.0221

0.0161 52 週間の範囲 4.2442

時価総額

11.026M

前日終値

0.0213

始値

0.0209

時刻

45000

0.0213

(formt)

最終取引時間

財務取引量

US$ 4,162,263

VWAP

0.020878

平均取引量 (3 か月)

117,199,591

発行済株式数

517,661,269

配当利回り

PER

-2.41

1 株当たり利益 (EPS)

-0.01

歳入

1.71M

純利益

-4.3M

Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed... Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California. 詳細を表示

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

elevailabs.com

本社

Wilmington, Delaware, USA

設立

Elevai Labs Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker ELAB. The last closing price for Elevai Labs was US$0.02. Over the last year, Elevai Labs shares have traded in a share price range of US$ 0.0161 to US$ 4.2442.

Elevai Labs currently has 517,661,269 shares in issue. The market capitalisation of Elevai Labs is US$11.03 million. Elevai Labs has a price to earnings ratio (PE ratio) of -2.41.

CORRECTION - Elevai Labs Inc.

NEWPORT BEACH, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- In a release earlier today by Elevai Labs Inc. (NASDAQ: ELAB), please note that in the headline and first paragraph, the financial...

Elevai Labs Inc. Reports Financial Results for the Second Fiscal Quarter of 2024 and Provides Business Update

Achieves Robust Financial Performance with 74% Gross Margin and Strategic Public Offering, Bolstering Resources for Continued Growth and Innovation.Elevai Enfinity™ Clinical Trials Showcase...

Elevai Labs Inc. Announces Update and Extension of Pending Offer to Exchange

NEWPORT BEACH, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Elevai Labs, Inc. (NASDAQ: ELAB) (“Elevai” or the “Company”), a leader in medical aesthetics, announced today that it is has amended and...

Form SC TO-I/A - Tender offer statement by Issuer: [Amend]

Form 8-K - Current report

Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Engages Leading Contract Research Organization (CRO) to Support Regulatory Planning Efforts and Pre-IND Meeting with the Food and Drug Administration For EL-22 For The Treatment of Obesity

NEWPORT BEACH, Calif., Oct. 22, 2024 (GLOBE NEWSWIRE) -- EL-22 is a novel myostatin asset for the potential treatment of obesity in combination with existing GLP-1 medicinesThe Investigational...

Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Highlights Past Positive Preclinical Data Showing Potential of EL-32, A Dual Myostatin & Activin-A Blocker, For the Treatment of Obesity

Preclinical results of EL-32 demonstrated statistically significant increases in grip strength, motor function and body composition in aged C57BL/6J mouse model.Elevai believes that EL-32 has the...

Form DEF 14C - Other definitive information statements

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.0013	6.5	0.02	0.0441	0.0191	631443995	0.02487679	CS
4	-0.0847	-79.9056603774	0.106	0.184	0.0161	298278461	0.02931444	CS
12	-0.2962	-93.2913385827	0.3175	0.376	0.0161	117199591	0.04314053	CS
26	-0.6638	-96.8909648227	0.6851	0.7	0.0161	55097158	0.04646617	CS
52	-3.9787	-99.4675	4	4.2442	0.0161	28419584	0.06350594	CS
156	-3.9787	-99.4675	4	4.2442	0.0161	28419584	0.06350594	CS
260	-3.9787	-99.4675	4	4.2442	0.0161	28419584	0.06350594	CS

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
FBRXForte Biosciences Inc	US$ 13.60 (129.53%)	29.6M
QSIQuantum Si Inc	US$ 1.39 (119.59%)	283.09M
XCURExicure Inc	US$ 11.01 (89.18%)	22.93M
AGFYAgrify Corporation	US$ 37.4635 (68.00%)	924.44k
SLXNSilexion Therapeutics Corporation	US$ 0.3495 (54.51%)	200.06M
SKKSKK Holdings Limited	US$ 4.55 (-47.28%)	816.93k
QMMMQMMM Holdings Limited	US$ 0.713999 (-43.78%)	4.61M
XTKGX3 Holdings Company Ltd	US$ 0.0901 (-37.82%)	5.95M
PRFXPainReform Ltd	US$ 1.02 (-27.14%)	5.09M
GLEGlobal Engine Group Holding Ltd	US$ 3.81 (-26.59%)	230.23k
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.191 (17.39%)	651.25M
DBGIDigital Brands Group Inc	US$ 0.1345 (15.35%)	325.57M
NVDANVIDIA Corporation	US$ 145.89 (-0.76%)	304.46M
QSIQuantum Si Inc	US$ 1.39 (119.59%)	279.33M
ELABElevai Labs Inc	US$ 0.0211 (-0.94%)	198.72M